Latest Freenome News & Updates

See the latest news and media coverage for Freenome. We track all announcements, press releases, and industry mentions in real time, all in one place.

Freenome

Biotech company developing blood tests for early cancer detection

freenome.com

Headquarters: Brisbane, United States
Founded year: 2014
Company type: Private company
Number of employees: 350–500

Last updated Today

Latest news about Freenome

In short: Freenome reached a $330 million SPAC deal to go public and secured inclusion in the updated ACS colorectal cancer screening guideline.

Company announcements

June 18 Freenome

Freenome and PCSC announce effective registration statement

The SEC declared the Form S-4 effective; shareholder meeting set for July 9, 2026, with closing expected in July.

May 27 Freenome

ACS includes Freenome's blood test in colorectal screening guideline

The guideline adds a new blood-based test category to improve screening rates. SimpleScreen CRC is under FDA review with approval expected mid-2026.

January 12 Freenome

Freenome expands AI and deep learning initiatives with NVIDIA

The collaboration aims to improve analytical speed and accuracy of blood-based cancer screening tests.

5 December 2025 Freenome

Freenome announces business combination agreement with PCSC

The deal includes $240M PIPE, creating a publicly listed company targeting multi-cancer detection, with ~$330M in proceeds and Nasdaq listing under FRNM.

Media coverage

June 18 Yahoo Finance

Perceptive Capital Solutions Corp and Freenome Announce Effectiveness of Registration Statement for Proposed Business Combination

Perceptive Capital Solutions Corp ("PCSC") (Nasdaq: PCSC), a special purpose acquisition company ("SPAC") sponsored by an affiliate of Perceptive Advisors, and Freenome Holdings, Inc. ("Freenome...

May 28 PR Newswire

Freenome's SimpleScreen™ CRC Blood-Based Test Included in Updated ACS Colorectal Cancer Screening Guideline

/PRNewswire/ -- Freenome, an early cancer detection company developing blood-based screening tests, welcomes the inclusion of blood-based testing in the...

March 18 PR Newswire

Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer

/PRNewswire/ -- Freenome, an early cancer detection company developing blood-based screening tests, today announced initial development data for its...

7 December 2025 Yahoo Finance

Freenome inks deals to list stock and raise $330M

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or...

Never miss news about Freenome

Track Freenome and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Freenome competitors & trending companies

Browse news for competitors to Freenome and other trending companies.